FRANKFURT, Germany–(BUSINESS WIRE)–OFB Projektentwicklung has started the first construction phase of the “BioSquare Leipzig” on a partial area of around 11,600 m² of the construction site 6a on the street “Alte Messe.” The symbolic groundbreaking ceremony on September 22, 2022, took place in the presence of Thomas Dienberg (Mayor for Urban Development and Construction of … [Read more…]
LifeWorks survey reveals Canadian organizations are experiencing the impacts of inflation and labour shortages during world-wide uncertainty TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its 40th annual Salary Projection Survey. The findings revealed much higher Canadian base salaries than initially projected, increasing 4.01 per cent in 2022 and … [Read more…]
Preliminary data set presented at EORTC CLTG annual meeting confirms clinical activity and favorable safety profile of lacutamab in patients with mycosis fungoides who express KIR3DL2 and who were previously treated with at least two lines of systemic therapy MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) … [Read more…]
HALIFAX, Nova Scotia–(BUSINESS WIRE)–Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced the results from its annual and special meeting of shareholders held earlier today. Based on the proxies received and the vote conducted at the meeting, all tabled … [Read more…]
20 new doctors slated to join EyeSouth’s affiliate practices throughout the country ATLANTA–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: EYESOUTH PARTNERS CELEBRATES LARGEST INCOMING DOCTOR CLASS SINCE ITS FOUNDING IN 2017 20 new doctors slated to join EyeSouth’s affiliate practices throughout the country EyeSouth … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) voiced support today for new legislation dubbed “a 21st-century global health solidarity strategy,” which calls for the U.S. to spend $125 billion annually to help lower-income countries build more resilient and sustainable health systems, according to Politico Pro. The resolution, slated to be introduced this week by three members … [Read more…]
Vaccines and Related Biological Products Advisory Committee reviewed data from the biologics license application for RBX2660 RBX2660 is an investigational microbiota-based live biotherapeutic studied for its potential to reduce recurrence of C. difficile infection after antibiotic treatment Recurrent C. difficile infection represents a significant burden for patients, caregivers, and the healthcare system SAINT-PREX, Switzerland & … [Read more…]
The company ranked #3 as a first-time applicant HOUSTON–(BUSINESS WIRE)–Isikel, a leading manufacturer and distributor of medical supplies, announced today that the company ranked #3 on the Houston Business Journal’s Fast 100 and Innovation list. This is the first time Isikel has been ranked in the HBJ Fast 100 and Innovation list since the company … [Read more…]
To prioritize education about women’s health, Tampax® Donates $100,000 to EndoFound’s ENPOWR™ education program. NEW YORK–(BUSINESS WIRE)–#UpEndo–The Endometriosis Foundation of America (EndoFound) announced today that it had received a $100,000 donation from Procter and Gamble (P&G) brand Tampax® to expand EndoFound’s education programs. These programs include the ENPOWR™ (Endometriosis: Promoting Outreach and Wide Recognition) Project, … [Read more…]
BOSTON–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug Administration’s (“FDA”) Oncologic Drugs Advisory Committee (“ODAC”) met to review poziotinib for the treatment of patients with previously treated locally advanced or metastatic non-small cell lung cancer (“NSCLC”) … [Read more…]
